Prob just the terms (CR, consolidation and timeframe). I personally don't like it. Particularly consolidation.I follow because the directors are also associated with one of the stocks I hold ACU.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025